Medpace Holdings, Inc. (MEDP)
591.29
-2.10
(-0.35%)
USD |
NASDAQ |
Sep 04, 16:00
591.66
+0.37
(+0.06%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 16.46B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 22.59% |
| Valuation | |
| PE Ratio | 34.68 |
| PE Ratio (Forward) | |
| PS Ratio | 6.126 |
| Price to Book Value | 37.94 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.3322 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 42.87% |
Profile
| Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. |
| URL | http://www.medpace.com |
| Investor Relations URL | https://investor.medpace.com/ |
| HQ State/Province | Ohio |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Oct. 19, 2026 (est.) |
| Last Earnings Release | Jul. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. |
| URL | http://www.medpace.com |
| Investor Relations URL | https://investor.medpace.com/ |
| HQ State/Province | Ohio |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Oct. 19, 2026 (est.) |
| Last Earnings Release | Jul. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |